Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi Grows Clinical Trials During Pandemic With Use Of Inhouse Clinical Supply Chain

Feb 10 2021

• By Brenda Sandburg

Deserted highway with the text COVID-19 — Sanofi surmounts COVID-19 roadblocks to keep clinical trials on track • Source: Shutterstock

Related Content

Clinical Trial Sponsors Should Consider Changing Data Collection Amid COVID-19, US FDA Says

Mar 19 2020

Sanofi Bids €308m To Buy Kiadis

Nov 02 2020

Sanofi CEO Takes Not-So-Slow And Steady Approach To COVID-19 Vaccines

Nov 10 2020

Strategic M&A: Sanofi Buys Principia Biopharma For $3.7bn

Aug 17 2020

Coronavirus Update: End Of The Road For Kevzara In COVID-19

Sep 02 2020

Sanofi Bets Big On IO With Synthorx Buy

Dec 09 2019

Cost-Cutting Sanofi Resumes Fitusiran Studies, Starts COVID Vaccine Phase IIb This Month

Feb 05 2021

Related Companies

Sanofi

GSK plc

Regeneron Pharmaceuticals, Inc.

Synthorx, Inc.

Principia Biopharma, Inc.

Additional Topics

Coronavirus COVID-19 Clinical Trials M & A Regulation BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window